TOBACCO-FREE KIDS ACTION FUND

Lobbying Report: October 1st -December 31st, 2025 (Action Fund)  Federal (under tobacco issue code)   Legislation:   Comprehensive Tobacco Control Legislation H.R. 5342/S. 2354, FY 26 Commerce, Justice, Science, and Related Agencies Appropriations Act H.R. 6845/S. 3569, Strengthening Task Force Operations to Prevent Illicit Vaping Act (S.T.O.P. Illicit Vaping Act) H.R. 5304/S. 2587, FY 26 Labor, Health and Human Services, Education, and Related Agencies Appropriations Act H.R. 6844, Tracking, Reporting, and Accountability for Compliance in Enforcement Act (Tobacco TRACE Act) H.R. 4779, FY 26 National Security, Department of State, and Related Programs Appropriations Act FY 26 Senate State, Foreign Operations, and Related Programs Appropriations Act H.R. 4121/S. 2256, FY 26 Agriculture, Rural Development, and Related Agencies Appropriations Act H.R. 5371, FY 26 Continuing Appropriations, Agriculture, Leg. Branch, MCVA and Extensions Act H.R. 2111 Premium Cigar Bill Issues: CDC Office on Smoking and Health funding Congressional Caucus to Prevent Youth Vaping FDA authority over tobacco products Federal multi-agency task force to combat the illegal distribution and sale of e-cigarettes CDC Chronic disease prevention programs FDA authorization of tobacco products FDA tobacco product destruction authority FDA enforcement against unauthorized tobacco products Tobacco Harm Reduction Caucus Agencies Visited:   Food and Drug Administration  US House of Representatives   US Senate  

GHAI Overdose Initiative (under healthcare issue code): Legislation: FY 26 Appropriations bills Modernizing Opioid Treatment Access Act PEER Support Act H.R. 5420 - Workplace Overdose Reversal Kits to Save Lives Act S.3522 - No Red Tape For Addiction Treatment Act S. 1165/H. R. 2586, Reentry Act S. 1720/H.R. 1510, Due Process Continuity of Care Act S. 2697, Due Process Continuity of Care Act SUPPORT for Patients and Communities Reauthorization Act Issues:  Medicaid prior authorization requirements Access to medications for opioid use disorder Overdose prevention Racial disparities in overdose deaths Agencies Visited:  Centers for Disease Control and Prevention US House of Representatives  US Senate